Skip to main content
. 2021 Mar 17;113(10):1369–1378. doi: 10.1093/jnci/djab034

Figure 4.

Figure 4.

Functional Assessment of Cancer Therapy–Ovary Trial Outcome Index (FACT-O-TOI) by survivorship and quartiles of grade 2 or higher adverse events (AEs). Long-term survivors have higher FACT-O-TOI at cycle 4 (P = .05) and cycle 21 (P = .02). FACT-O-TOI decreases with increasing grade 2 or higher AEs at cycle 4 (P < .001) and cycle 21 (P = .02). Data are tested using a 2-sided F test. Error bars represent ±1 standard error. Q = quartile.